Cargando…

Sodium-Glucose Cotransporter Inhibitors as Antidiabetic Drugs: Current Development and Future Perspectives

[Image: see text] Sodium-glucose cotransporter 2 (SGLT-2) inhibitors (gliflozins) represent the most recently approved class of oral antidiabetic drugs. SGLT-2 overexpression in diabetic patients contributes significantly to hyperglycemia and related complications. Therefore, SGLT-2 became a highly...

Descripción completa

Detalles Bibliográficos
Autores principales: Maccari, Rosanna, Ottanà, Rosaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937539/
https://www.ncbi.nlm.nih.gov/pubmed/35924548
http://dx.doi.org/10.1021/acs.jmedchem.2c00867